Mark Arnold

817 total citations
37 papers, 503 citations indexed

About

Mark Arnold is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Mark Arnold has authored 37 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in General Health Professions. Recurrent topics in Mark Arnold's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Ethics in medical practice (4 papers). Mark Arnold is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Ethics in medical practice (4 papers). Mark Arnold collaborates with scholars based in Australia, United Kingdom and Switzerland. Mark Arnold's co-authors include Peter Brooks, Leslie Schrieber, Elaine Beller, A Tyndall, W. Watson Buchanan, Ian Kerridge, Lynden Roberts, Hedley Griffiths, Jane Zochling and Simon Burnet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Drugs.

In The Last Decade

Mark Arnold

35 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Arnold Australia 14 215 71 69 68 59 37 503
Robert J. Barry United Kingdom 14 136 0.6× 34 0.5× 79 1.1× 15 0.2× 17 0.3× 41 758
Rachel E. Sobel United States 12 215 1.0× 126 1.8× 44 0.6× 31 0.5× 21 0.4× 32 541
Meghna Jani United Kingdom 17 486 2.3× 173 2.4× 136 2.0× 93 1.4× 65 1.1× 60 1.1k
Jørgen Poulsen Denmark 14 147 0.7× 60 0.8× 53 0.8× 28 0.4× 53 0.9× 37 672
W. Clark United Kingdom 10 281 1.3× 116 1.6× 40 0.6× 51 0.8× 30 0.5× 15 741
Mary Altz‐Smith United States 7 310 1.4× 109 1.5× 41 0.6× 34 0.5× 67 1.1× 8 518
J Worthington United States 9 398 1.9× 66 0.9× 51 0.7× 45 0.7× 50 0.8× 13 782
Leena R. Baghdadi Saudi Arabia 10 201 0.9× 46 0.6× 28 0.4× 37 0.5× 4 0.1× 21 392
Maria Lourdes Gonzalez Suarez United States 15 41 0.2× 20 0.3× 103 1.5× 19 0.3× 23 0.4× 40 836
Anne McEntegart United Kingdom 8 386 1.8× 125 1.8× 36 0.5× 21 0.3× 32 0.5× 12 600

Countries citing papers authored by Mark Arnold

Since Specialization
Citations

This map shows the geographic impact of Mark Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Arnold more than expected).

Fields of papers citing papers by Mark Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Arnold. The network helps show where Mark Arnold may publish in the future.

Co-authorship network of co-authors of Mark Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Arnold. A scholar is included among the top collaborators of Mark Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Arnold. Mark Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hay, Jonathan, et al.. (2024). Broadening placement opportunities for nursing students through an indirect supervision model. BMC Nursing. 23(1). 491–491.
2.
Kerridge, Ian, George Skowronski, V. Venkatesha, et al.. (2023). Clinician perspectives on voluntary assisted dying and willingness to be involved: a multisite, cross‐sectional survey during implementation in New South Wales, Australia. Internal Medicine Journal. 54(5). 724–734. 1 indexed citations
3.
Lane, Stuart, et al.. (2023). The undue influence of genetic information on senior medical students’ treatment decisions. BMC Medical Education. 23(1). 938–938. 1 indexed citations
4.
Arnold, Mark, et al.. (2023). The Ethics of Overlapping Relationships in Rural and Remote Healthcare. A Narrative Review. Journal of Bioethical Inquiry. 20(2). 181–190. 3 indexed citations
5.
Arnold, Mark. (2021). Teasing out Artificial Intelligence in Medicine: An Ethical Critique of Artificial Intelligence and Machine Learning in Medicine. Journal of Bioethical Inquiry. 18(1). 121–139. 54 indexed citations
6.
Arnold, Mark, Ian Kerridge, & Wendy Lipworth. (2020). An Ethical Critique of Person-Centred Healthcare. European Journal for Person Centered Healthcare. 8(1). 34–44. 6 indexed citations
7.
Arnold, Mark & Ian Kerridge. (2020). Accelerating the De-Personalization of Medicine: The Ethical Toxicities of COVID-19. Journal of Bioethical Inquiry. 17(4). 815–821. 4 indexed citations
8.
Arnold, Mark, Paul A. Komesaroff, & Ian Kerridge. (2020). Understanding the ethical implications of the rituals of medicine. Internal Medicine Journal. 50(9). 1123–1131. 5 indexed citations
9.
Arnold, Mark, et al.. (2018). Chronic gout: Barriers to effective management. Australian Journal of General Practice. 47(6). 351–356. 3 indexed citations
10.
Bird, Paul, Hedley Griffiths, Kathleen Tymms, et al.. (2013). The SMILE Study — Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis. The Journal of Rheumatology. 40(3). 228–235. 38 indexed citations
11.
Arnold, Mark, et al.. (2009). Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report. Journal of orthopaedic surgery. 17(1). 103–108. 11 indexed citations
12.
Arnold, Mark, Valerie Corrigall, Costantino Pitzalis, & G S Panayi. (1994). The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.. PubMed. 11(6). 629–34. 16 indexed citations
13.
Schwarzer, Anthony C., Michael G. Cohen, Mark Arnold, et al.. (1990). Tenoxicam compared with diclofenac in patients with ankylosing spondylitis. Current Medical Research and Opinion. 11(10). 648–653. 13 indexed citations
14.
Schwarzer, Anthony C., Mark Arnold, Diane Kelly, et al.. (1990). THE CYCLING OF COMBINATION ANTIRHEUMATIC DRUG THERAPY IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 29(6). 445–450. 8 indexed citations
15.
Arnold, Mark, James P. O’Callaghan, Margaret McCredie, et al.. (1990). COMPARATIVE CONTROLLED TRIAL OF LOW-DOSE WEEKLY METHOTREXATE VERSUS AZATHIOPRINE IN RHUEMATIOD ARTHRITIS: 3-YEAR PROSPECTIVE STUDY. Lara D. Veeken. 29(2). 120–125. 29 indexed citations
16.
Arnold, Mark, et al.. (1989). A destructive discovertebral lesion: Septic discitis, ankylosing spondylitis, or rheumatoid arthritis ?. Clinical Rheumatology. 8(2). 277–281. 4 indexed citations
17.
Arnold, Mark, et al.. (1989). Sjögren's syndrome beyond the eye. Australian and New Zealand Journal of Ophthalmology. 17(2). 111–120. 1 indexed citations
18.
Arnold, Mark, Leslie Schrieber, & Peter Brooks. (1988). Immunosuppressive Drugs and Corticosteroids in the Treatment of Rheumatoid Arthritis. Drugs. 36(3). 340–363. 13 indexed citations
19.
Arnold, Mark, et al.. (1988). TOPHACEOUS GOUT OF THE AXIAL SKELETON. Australian and New Zealand Journal of Medicine. 18(7). 865–867. 18 indexed citations
20.
Arnold, Mark & Leslie Schrieber. (1988). Splendic and renal infarction in systemic lupus erythematosus: Association with anti-cardiolipin antibodies. Clinical Rheumatology. 7(3). 406–410. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026